Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378. Global Cardiology, [S. l.], v. 2, n. 4, 2024. DOI: 10.4081/cardio.2024.56. Disponível em: https://www.globalcardiology.info/site/article/view/56. Acesso em: 7 jun. 2025.